02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
25/11/2022

The time to act is now! Biotechnology for global transformation

11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

24/10/2022

European Biotech Week 2022: Bringing Biotech to Local Communities

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

19/10/2022

#EFIB2022:  Industrial biotechnology community comes together in Vilnius next week

06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum

30/09/2022

Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe

25/09/2022

European Biotech Week 2022 starts today!

19/09/2022

Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.

14/09/2022

Registration is open to the main events of the 10th edition of the European Biotech Week

07/09/2022

Advanced therapy medicinal products: SMEs call for a better investment environment in Europe

07/09/2022

Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

07/09/2022

Factsheet – European Health Data Space

07/09/2022

Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

07/09/2022

Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

27/07/2022

EuropaBio position on the European Health Data Space proposal

18/07/2022

EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)

07/07/2022

EuropaBio Statement on the publication of the New European Innovation Agenda

29/06/2022

EuropaBio’s Vision for Europe: Innovation, Investment, Excellence